Saturday, 19 February 2022

Covaxin Set To Be Evaluated In US, Says Maker Bharat Biotech

Bharat Biotech on Saturday said its Covaxin will be evaluated as a COVID-19 vaccine candidate in the US.

from NDTV News - Special https://ift.tt/v9T4NAJ
via
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

OnePlus Nord 6 Review: Finally, a Mid-Ranger Without Compromise

The OnePlus Nord 6 feels like a stellar return to what made the Nord lineup relevant in the first place, capturing that elusive value-driven...